| BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 | ||||
| Theme: Rethinking the Next Big Things in Pharma Innovations | ||||
| Time: August 16-19, 2018 Place: Boston Marriott Cambridge, USA |
||||
| Scientific Program | ||||
| Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
| Stream 3: Industrial Art Gallery -Arts in Billion Dollar Molecules and Next Generation Therapy |
Substream 3-1: Improved Linear Drug Discovery on Selected Current Drug Targets Substream 3-6: Clinical Trial Gateway and Translational Convergence |
| Substream 3-7: Arts of Next Generation Therapy |
|||
|
Session 3701: Anticancer Drugs and Cancer Therapies Day 2: Morning, Friday, August 17, 2018 Place: Discovery Room, 3rd Floor 10:10-12:15 |
|||
| Chair: Dr. Alain L. Fymat, President/CEO and Professor, International Institute of Medicine and Science, USA | |||
| Time | FaceOn | Speeches and Speakers | |
| 10:10-10:15 | Chair's Introduction | ||
| 10:15-10:35 |  |
Title: Preventing Post-surgical Lung Cancer Recurrence with Localized Drug Delivery Dr. Eyal S. Ron, Principal, MADASH, LLC, USA |
|
| 10:35-10:55 |  |
Title: Glioblastoma Treatments: Where Do We Stand? Dr. Alain L. Fymat, President/CEO and Professor, International Institute of Medicine and Science, USA |
|
| 10:55-11:15 |  |
Title: Small Molecule Inhibitors in the Treatment of CLL Dr. Ryan W Jacobs, Co-Director of Apheresis, Levine Cancer Institute/Carolinas HealthCare System, USA |
|
| 11:15-11:35 |  |
Title: CDK6 as a New Therapeutic Target in T-ALL Dr. Miaofen G Hu, Assistant Professor, TUFTS Medical Center, USA |
|
| 11:35-11:55 |  |
Title: Development of a New Class of Pt Anticancer Drug
Dr. Arindam Sarkar, Principal Scientist, Invictus Oncology; Fellow, India Innovation Research Center, India |
|
| 11:55-12:15 |  |
Title: Capital Efficient Development of a Novel Oncology Drug Dr. Lawrence Friedhoff, Chief, Research & Development, Roivant Sciences, Inc., USA |
|
|
Session 3702: Drugs against Diabetes and Diabetes Therapies Day 3: Morning, Saturday, August 18, 2018 Place: Enterprise Room, 3rd Floor 10:25-11:45 |
|||
| Chair: Dr. Basset ElEssawy, Professor, Al-Azhar University, Egypt; Ras AlKhaimah Meidcal Health and Science University, UAE | |||
| Time | FaceOn | Speeches and Speakers | |
| 10:25-10:30 | Chair's Introduction | ||
| 10:30-10:55 |  |
Title: Long Term Prevention of Cardiovascular Adverse Events in Diabetic Rats by Incorporation of Ocimum and Nigella Extracts Dr. Mona El-Husseiny, Professor of Physiology, Cairo University, Egypt |
|
| 10:55-11:20 |  |
Title: How to Treat Infected Diabetic Foot with Photodynamic Therapy - Risk Score and Results Dr. Joao Paulo Tardivo, Assistant Professor, Faculdade de Medicina do ABC, Brazil |
|
| 11:20-11:45 |  |
Title: Type 1DM and T-Regulatory Cells Dr. Basset ElEssawy, Professor, Al-Azhar University, Egypt; Ras AlKhaimah Meidcal Health and Science University, UAE |
|
|
Session 3703: Cardiovascular Disease Drugs and Therapies Day 3: Afternoon, Saturday, August 18, 2018 Place: Endeavor Room, 3rd Floor 15:30-17:35 |
|||
| Chair: Dr. Ming-Yow Hung, Director, Cardiac Catheterization Laboratory, Shuang Ho Hospital, Taipei Medical University, Taiwan | |||
| Time | FaceOn | Speeches and Speakers | |
| 15:30-15:35 | Chair's Introduction | ||
| 15:35-15:55 |  |
Title: Can Pragmatic Trials Advance Cardiovascular Drug Discovery? Dr. Jacob Joseph, Associate Professor of Medicine, Harvard Medical School, USA |
|
| 15:55-16:15 |  |
Title: Development of Omega-3 Epoxyeicosanoid Analogs for the Treatment of Cardiovascular and Inflammatory Diseases Dr. Wolf-Hagen Schunck, Head, Max Delbrueck Center for Molecular Medicine; Co-founder, OMEICOS Therapeutics, Germany |
|
| 16:15-16:35 |  |
Title: Immunity in Coronary Artery Spasm
Dr. Ming-Yow Hung, Director, Cardiac Catheterization Laboratory, Shuang Ho Hospital, Taipei Medical University, Taiwan |
|
| 16:35-16:55 |  |
Title: Lunar Hypertension and Urban Pollution Dr. William J. Rowe, Former Clinical Assistant Professor of Medicine, Medical University of Ohio, USA |
|
| 16:55-17:15 |  |
Title: Evaluation of Peripheral Circulation with Vascular Access by Measuring Skin Perfusion Pressure Dr. Makoto Sato, General Director, Department of Plastic Surgery, Seirei Mikatahara General Hospital, Japan |
|
| 17:15-17:35 |  |
Title: Network Pharmacology-based Discovery of Natural and Herbal Anti-inflammatory Agents Co-targeting Ischemic Brain and Heart Diseases Dr. Yan Zhu, Professor and Executive Deputy Director, Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, China |
|
|
Session 3704: CNS and Neurodegenerative Disorders Drugs and Therapies Day 3: Afternoon, Saturday, August 18, 2018 Place: Enterprise Room, 3rd Floor 13:30-17:10 |
|||
| Chair: Dr. Guochuan Emil Tsai, CEO, SyneuRx; Professor, David Geffen School of Medicine, University of California at Los Angeles, USA | |||
| Co-Chair: Dr. Klaus van Leyen, Associate Professor, Harvard Medical School and Massachusetts General Hospital, USA | |||
| Time | FaceOn | Speeches and Speakers | |
| 13:30-13:35 | Chair's Introduction | ||
| 13:35-14:00 |  |
Title: Migraine and Cranial Neuralgias: Current and Emerging Therapeutics Dr. Paul G. Mathew, Assistant Professor of Neurology, Harvard Medical School, USA
|
|
| 14:00-14:25 |  |
Title: Facilitating NMDA System Balance to Address CNS Disorders Dr. Guochuan Emil Tsai, CEO, SyneuRx; Professor, David Geffen School of Medicine, University of California at Los Angeles, USA |
|
| 14:25-14:50 |  |
Title: A New Generation of Conformation-specific Antibodies against an Early Driver of Neurodegeneration for Treating Brain Injury and Alzheimer's Disease Dr. Xiao Zhen Zhou, Assistant Professor, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, USA |
|
| 14:50-15:15 |  |
Title: The Importance of Incorporating Upper Motor Neurons in Preclinical Assays for Drug Discovery Efforts Dr. P. Hande Ozdinler, Associate Professor, Department of Neurology, Northwestern University, Chicago, IL, USA |
|
| 15:15-15:30 | Coffee Break | ||
| 15:30-15:55 |  |
Title: Development of Novel Therapeutics for Treatment of Huntington's Disease Dr. Xin Qi, Associate Professor, Case Western Reserve University, USA |
|
| 15:55-16:20 |  |
Title: Hydralazine Induces Stress Resistance and Extends C. elegans Lifespan by Activating the NRF2/SKN-1 Signaling Pathway Dr. Hamid Mirzaei, Assistant Professor of Biochemistry, University of Texas Southwestern Medical Center, USA |
|
| 16:25-16:45 |  |
Title: Lipoxygenase Inhibition as a Multipronged Strategy to Treat Stroke Dr. Klaus van Leyen, Associate Professor, Department of Radiology, Massachusetts General Hospital, USA |
|
| 16:45-17:10 |  |
Title: M3 Biotechnology: Neuro-regenerative Disease-modifying Therapies Dr. Kevin Church, Senior Research Scientist, M3 Biotechnology, Inc., USA |
|
|
Session 3705: Other Disease Drugs and Therapies Day 3: Afternoon, Saturday, August 18, 2018 Place: Discovery Room, 3rd Floor 15:10-17:15 |
|||
| Chair: Dr. Lakshminarayan Ranganath, Clinical Director, United Kingdom National Alkaptonuria Centre, UK |
|||
| Time | FaceOn | Speeches and Speakers | |
| 15:10-15:15 | Chair's Introduction | ||
| 15:15-15:35 |  |
Title: Repurposing Nitisinone in Alkaptonuria (AKU) Dr. Lakshminarayan Ranganath, Clinical Director, United Kingdom National Alkaptonuria Centre, UK |
|
| 15:35-15:55 |  |
Title: Halogenated Hydroxyquinolines as Promising Anti-infective Agents Dr. Josef Jampilek, Professor, Faculty of Pharmacy, Comenius University, Slovakia |
|
| 15:55-16:15 |  |
Title: Mechanisms of Action and Effects of Photobiomodulation in Diabetic Wounds Dr. Nicolette N. Houreld, Associate Professor, University of Johannesburg, South Africa
|
|
| 16:15-16:35 |  |
Title: Pharmacological Modulation of GITRL/GITR System in Autoimmune / Inflammatory Disease Models Dr. Carlo Riccardi, Director, Department of Medicine, University of Perugia, Italy |
|
| 16:35-16:55 |  |
Title: Acute Appendicitis with Neuroendocrine Tumor G1 (carcinoid): Pitfalls of ConservativeTreatment Dr. Hiroyuki A. Watanabe, Kohnan Aozora, Facility for the Elderly, Japan |
|
| 16:55-17:15 |  |
Title: Medical Treatment of Uric Acid Urolithiasis
Dr. Michel Normand, Nephrologist, Service De Néphrologie, Hôpital Privé Saint-Martin, France
|
|
© 2003-2018 All rights reserved by BITeomics Inc. |